In this study, nucleoside transporter inhibition assay showed that dipyridamole decreased the anti-proliferative activity of gemcitabine, but has little influence on the cytotoxic effect of G12msi against GPC3-positive HCC cells. The gene discussed is GPC3; the disease is hepatocellular carcinoma.